| Home > Publications Database > The Anaesthetics Isoflurane and Xenon Reverse the Synaptotoxic Effects of Aβ1-42 on Megf10-Dependent Astrocytic Synapse Elimination and Spine Density in Ex Vivo Hippocampal Brain Slices. |
| Journal Article | DZNE-2023-00167 |
; ; ; ;
2023
Molecular Diversity Preservation International
Basel
This record in other databases:
Please use a persistent id in citations: doi:10.3390/ijms24020912
Abstract: It has been hypothesised that inhalational anaesthetics such as isoflurane (Iso) may trigger the pathogenesis of Alzheimer's disease (AD), while the gaseous anaesthetic xenon (Xe) exhibits many features of a putative neuroprotective agent. Loss of synapses is regarded as one key cause of dementia in AD. Multiple EGF-like domains 10 (MEGF10) is one of the phagocytic receptors which assists the elimination of synapses by astrocytes. Here, we investigated how β-amyloid peptide 1-42 (Aβ1-42), Iso and Xe interact with MEGF10-dependent synapse elimination. Murine cultured astrocytes as well as cortical and hippocampal ex vivo brain slices were treated with either Aβ1-42, Iso or Xe and the combination of Aβ1-42 with either Iso or Xe. We quantified MEGF10 expression in astrocytes and dendritic spine density (DSD) in slices. In brain slices of wild type and AAV-induced MEGF10 knock-down mice, antibodies against astrocytes (GFAP), pre- (synaptophysin) and postsynaptic (PSD95) components were used for co-localization analyses by means of immunofluorescence-imaging and 3D rendering techniques. Aβ1-42 elevated pre- and postsynaptic components inside astrocytes and decreased DSD. The combined application with either Iso or Xe reversed these effects. In the presence of Aβ1-42 both anaesthetics decreased MEGF10 expression. AAV-induced knock-down of MEGF10 reduced the pre- and postsynaptic marker inside astrocytes. The presented data suggest Iso and Xe are able to reverse the Aβ1-42-induced enhancement of synaptic elimination in ex vivo hippocampal brain slices, presumably through MEGF10 downregulation.
Keyword(s): Mice (MeSH) ; Animals (MeSH) ; Isoflurane: pharmacology (MeSH) ; Xenon: pharmacology (MeSH) ; Xenon: metabolism (MeSH) ; Astrocytes: metabolism (MeSH) ; Amyloid beta-Peptides: metabolism (MeSH) ; Brain: metabolism (MeSH) ; Hippocampus: metabolism (MeSH) ; Peptide Fragments: metabolism (MeSH) ; Alzheimer Disease: metabolism (MeSH) ; Anesthetics, Inhalation: pharmacology (MeSH) ; Synapses: metabolism (MeSH) ; Membrane Proteins: metabolism (MeSH) ; Alzheimer’s disease ; Alzheimer’s disease ; MEGF10 ; astrocytes ; dendritic spine density ; phagocytosis ; synapse elimination ; amyloid beta-protein (1-42) ; Isoflurane ; Xenon ; Amyloid beta-Peptides ; Peptide Fragments ; Anesthetics, Inhalation ; Megf10 protein, mouse ; Membrane Proteins
|
The record appears in these collections: |
Journal Article (Erratum/Correction)
Correction: Shi et al. The Anaesthetics Isoflurane and Xenon Reverse the Synaptotoxic Effects of Aβ1-42 on Megf10-Dependent Astrocytic Synapse Elimination and Spine Density in Ex Vivo Hippocampal Brain Slices. Int. J. Mol. Sci. 2023, 24, 912.
International journal of molecular sciences 26(18), 8797 (2025) [10.3390/ijms26188797]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS